Skip to main content

PDF Products

Protein synthesis proceeds after formylation of methionine by methionyl-tRNA formyl transferase (FMT) and transfer of the charged initiator f-met tRNA to the ribosome. In eubacteria and eukaryotic organelles the product of this gene, peptide deformylase (PDF), removes the formyl group from the initiating methionine of nascent peptides. In eubacteria, deformylation of nascent peptides is required for subsequent cleavage of initiating methionines by methionine aminopeptidase. The discovery that a natural inhibitor of PDF, actinonin, acts as an antimicrobial agent in some bacteria has spurred intensive research into the design of bacterial-specific PDF inhibitors. In human cells, only mitochondrial proteins have N-formylation of initiating methionines. Protein inhibitors of PDF or siRNAs of PDF block the growth of cancer cell lines but have no effect on normal cell growth. In humans, PDF function may therefore be restricted to rapidly growing cells. [provided by RefSeq]
Show More

75 results for "PDF" in Products

75 results for "PDF" in Products

PDF Products

Protein synthesis proceeds after formylation of methionine by methionyl-tRNA formyl transferase (FMT) and transfer of the charged initiator f-met tRNA to the ribosome. In eubacteria and eukaryotic organelles the product of this gene, peptide deformylase (PDF), removes the formyl group from the initiating methionine of nascent peptides. In eubacteria, deformylation of nascent peptides is required for subsequent cleavage of initiating methionines by methionine aminopeptidase. The discovery that a natural inhibitor of PDF, actinonin, acts as an antimicrobial agent in some bacteria has spurred intensive research into the design of bacterial-specific PDF inhibitors. In human cells, only mitochondrial proteins have N-formylation of initiating methionines. Protein inhibitors of PDF or siRNAs of PDF block the growth of cancer cell lines but have no effect on normal cell growth. In humans, PDF function may therefore be restricted to rapidly growing cells. [provided by RefSeq]
Show More
Applications: WB, ICC/IF, Flow
Reactivity: Human
Applications: WB
Reactivity: Human, Mouse, Rat
Applications: WB
Reactivity: Human
Applications: IHC, ICC/IF
Reactivity: Human
Applications: IHC
Reactivity: Human
Applications: AC
Applications: WB
Applications: WB, ICC/IF, Flow, CyTOF-ready
Reactivity: Human
Applications: WB, ICC/IF, Flow, CyTOF-ready
Reactivity: Human
Applications: WB, ICC/IF, Flow, CyTOF-ready
Reactivity: Human
Applications: WB, ICC/IF, Flow, CyTOF-ready
Reactivity: Human
Applications: IHC
Reactivity: Human
Applications: WB, ICC/IF, Flow, CyTOF-ready
Reactivity: Human
Applications: IHC
Reactivity: Human
Applications: IHC
Reactivity: Human
Applications: IHC
Reactivity: Human
Applications: IHC
Reactivity: Human
Applications: ICC/IF, Flow
Reactivity: Human
Applications: ICC/IF, Flow
Reactivity: Human
Applications: ICC/IF, Flow
Reactivity: Human
Applications: IHC
Reactivity: Human
Applications: ICC/IF, Flow
Reactivity: Human
Applications: ICC/IF, Flow
Reactivity: Human
Applications: ICC/IF, Flow
Reactivity: Human
Applications: ICC/IF, Flow
Reactivity: Human
Results Per Page
5 10 25 50
/ 3